Xspray Pharma AB (publ) (STO:XSPRAY)
Sweden · Delayed Price · Currency is SEK 9.20
-0.05 (-0.54%)
Sep 22, 2026, 5:29 PM CET
Xspray Pharma AB Market Cap
Xspray Pharma AB has a market cap or net worth of 436.23 million as of September 22, 2026. Its market cap has decreased by -80.13% in one year.
Market Cap
436.23M
Enterprise Value
403.63M
Revenue
2.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.20
ChartMarket Cap Chart
Since September 28, 2017, Xspray Pharma AB's market cap has increased from 375.71M to 436.23M, an increase of 16.11%. That is a compound annual growth rate of 1.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 436.23M | -66.77% |
| Dec 30, 2025 | 1.31B | -14.72% |
| Dec 30, 2024 | 1.54B | 23.14% |
| Dec 29, 2023 | 1.25B | -3.30% |
| Dec 30, 2022 | 1.29B | -2.48% |
| Dec 30, 2021 | 1.33B | -63.83% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Infant Bacterial Therapeutics AB | 875.64M |
| Oncopeptides AB | 816.66M |
| FluoGuide | 572.23M |
| Mendus AB | 428.39M |
| Cantargia AB | 390.07M |
| Corline Biomedical AB | 371.09M |
| Intervacc AB | 344.22M |
| Sprint Bioscience AB | 311.27M |